Structure | Chemical Name | CAS | MF |
|
5-O-ADAMANTANCARBONYL-2,3-O-ISOPROPYLIDENE-D-RIBOFURANOSE
|
177415-06-4
|
C19H28O6
|
|
3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol
|
177415-76-8
|
C20H18N4O2
|
|
Pyrazolo[5,1-b]quinazoline-5,8,9(4H)-trione, 2-amino-6,7-dichloro-3-(phenylazo)- (9CI)
|
177420-07-4
|
C16H8Cl2N6O3
|
|
Benzo[g]pyrazolo[5,1-b]quinazoline-5,10,11(4H)-trione, 2-amino-3-(phenylazo)- (9CI)
|
177420-11-0
|
C20H12N6O3
|
|
Benzo[g]pyrazolo[5,1-b]quinazoline-5,10,11(4H)-trione, 2-amino-3-[(4-methylphenyl)azo]- (9CI)
|
177420-12-1
|
C21H14N6O3
|
|
Benzoic acid, 2-broMo-3-(trifluoroMethyl)-
|
177420-63-2
|
C8H4BrF3O2
|
|
2-Bromo-6-(trifluoromethyl)benzoic acid 97%
|
177420-64-3
|
C8H4BrF3O2
|
|
2H-1,4-Thiazin-3(4H)-one, 2-acetyl-4-methyl- (9CI)
|
177421-80-6
|
C7H9NO2S
|
|
3-Pyridinecarbonitrile,1,4,5,6-tetrahydro-1-methyl-6-oxo-(9CI)
|
177422-93-4
|
C7H8N2O
|
|
Aglain C
|
177468-85-8
|
C36H42N2O8
|
|
(R)-2-AMINO-1,1,1-TRIFLUOROPROPANE HYDROCHLORIDE
|
177469-12-4
|
C3H7ClF3N
|
|
2H-Pyran-2-one,5,6-dihydro-5-methyl-6-(1-methylethyl)-,cis-(9CI)
|
177469-18-0
|
C9H14O2
|
|
2H-Pyran-2-one,5,6-dihydro-5-methyl-6-(1-methylethyl)-,trans-(9CI)
|
177469-19-1
|
C9H14O2
|
|
Unii-Q70OH404hr
|
177469-96-4
|
C35H37N3O2
|
|
Levofloxacin Impurity 22
|
177472-29-6
|
C20H25F2N3O4
|
|
Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate)
|
177472-30-9
|
C20H24FN3O4
|
|
Carbamic acid, [2-(hydroxymethyl)cyclopropyl]-, 1,1-dimethylethyl ester, (1S-
|
177472-48-9
|
C9H17NO3
|
|
Carbamic acid, [2-(hydroxymethyl)cyclopropyl]-, 1,1-dimethylethyl ester, (1R-
|
177472-54-7
|
C9H17NO3
|
|
Carbamic acid, [2-(hydroxymethyl)cyclopropyl]-, 1,1-dimethylethyl ester, (1S-
|
177472-60-5
|
C9H17NO3
|
|
2H-Isoindole-2-carboxylicacid,3a-amino-1,3,3a,7a-tetrahydro-,methylester,
|
177473-14-2
|
C10H14N2O2
|
|
2H-Isoindole-2-carboxylicacid,3a-amino-1,3,3a,7a-tetrahydro-,methylester
|
177473-19-7
|
C10H14N2O2
|
|
2,3-Aziridinedicarboxylicacid,dimethylester(9CI)
|
177473-22-2
|
C6H9NO4
|
|
2-Aziridinecarboxylicacid,1-acetyl-,methylester,(2R)-(9CI)
|
177473-24-4
|
C6H9NO3
|
|
BENZONITRILE, 3-METHOXY-4-NITRO-
|
177476-75-4
|
C8H6N2O3
|
|
Benzonitrile, 4-amino-3-methoxy- (9CI)
|
177476-76-5
|
C8H8N2O
|
|
1,2-Benzenediamine, 3-methoxy-N1-methyl-
|
177477-60-0
|
C8H12N2O
|
|
1H-Benzimidazole,4-methoxy-1,2-dimethyl-(9CI)
|
177477-61-1
|
C10H12N2O
|
|
1H-Benzimidazol-4-ol,1,2-dimethyl-(9CI)
|
177477-62-2
|
C9H10N2O
|
|
1H-Benzimidazol-4-ol,1-ethyl-2-methyl-(9CI)
|
177477-78-0
|
C10H12N2O
|
|
1H-Benzimidazol-4-ol,2-ethyl-1-methyl-(9CI)
|
177477-80-4
|
C10H12N2O
|
|
1H-Benzimidazol-4-ol,2-methoxy-1-methyl-(9CI)
|
177477-89-3
|
C9H10N2O2
|
|
1H-Benzimidazol-4-ol,1-methyl-2-(1-methylethyl)-(9CI)
|
177478-08-9
|
C11H14N2O
|
|
1H-Benzimidazol-4-ol,2-ethoxy-1-methyl-(9CI)
|
177478-23-8
|
C10H12N2O2
|
|
1H-Benzimidazol-4-ol,2-(methoxymethyl)-1-methyl-(9CI)
|
177478-24-9
|
C10H12N2O2
|
|
Ethanone, 1-(4-hydroxy-1-methyl-1H-benzimidazol-2-yl)- (9CI)
|
177478-25-0
|
C10H10N2O2
|
|
1H-Benzimidazol-4-ol,2-(dimethylamino)-1-methyl-(9CI)
|
177478-28-3
|
C10H13N3O
|
|
Phenol, 2-amino-3-(ethylamino)-
|
177478-31-8
|
C8H12N2O
|
|
1H-Benzimidazol-4-ol,1-methyl-2-(methylamino)-(9CI)
|
177478-32-9
|
C9H11N3O
|
|
1,2,3,4-TETRAHYDRO-QUINOLINE-6-CARBOXYLIC ACID METHYL ESTER
|
177478-49-8
|
C11H13NO2
|
|
2H-[1,3]Oxazino[3,2-a]benzimidazol-9-ol,3,4-dihydro-(9CI)
|
177478-61-4
|
C10H10N2O2
|
|
Methyl 2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylate
|
177478-63-6
|
C11H11NO3
|
|
4-BROMO-2-CHLORO-5-FLUOROBENZOIC ACID
|
177480-81-8
|
C7H3BrClFO2
|
|
2,4-Hexanedione, 3-hydroxy- (9CI)
|
177483-75-9
|
C6H10O3
|
|
Bicyclo[3.3.1]nonane, 1,5-difluoro- (9CI)
|
177483-89-5
|
C9H14F2
|
|
ethyl imidazo[1,2-a]pyridine-5-carboxylate
|
177485-39-1
|
C10H10N2O2
|
|
Imidazo[1,2-a]pyridine-5-carboxylic acid, 3-amino-, ethyl ester (9CI)
|
177485-58-4
|
C10H11N3O2
|
|
3H-1,4,8b-Triazaacenaphthylene-3,5(4H)-dione(9CI)
|
177485-64-2
|
C9H5N3O2
|
|
Carbamic acid, (3-azido-1-methylpropyl)-, methyl ester (9CI)
|
177489-84-8
|
C6H12N4O2
|
|
Carbamic acid, (4-azidobutyl)-, methyl ester (9CI)
|
177489-87-1
|
C6H12N4O2
|
|
Carbamic acid, (4-azido-1-methylbutyl)-, methyl ester (9CI)
|
177489-88-2
|
C7H14N4O2
|
|
(3-AMINO-1-METHYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER
|
177489-90-6
|
C9H20N2O2
|
|
1H-1,2,3-Triazole-4-carboxylicacid,4,5-dihydro-1-methyl-,methylester(9CI)
|
177490-39-0
|
C5H9N3O2
|
|
1H-1,2,3-Triazole-4-carboxylicacid,4,5-dihydro-1,5-dimethyl-,methylester
|
177490-44-7
|
C6H11N3O2
|
|
4-ACETOXYPHENYLBORONIC ACID
|
177490-82-3
|
C8H9BO4
|
|
1,3-BENZOXAZOL-6-AMINE
|
177492-52-3
|
C7H6N2O
|
|
DIETHYL 2-[(1,3-BENZOXAZOL-5-YLAMINO)METHYLENE]MALONATE
|
177492-53-4
|
C15H16N2O5
|
|
Cyclohexanecarboxaldehyde, 2-(1-propenyl)-, [1alpha,2beta(E)]- (9CI)
|
177493-79-7
|
C10H16O
|
|
6-BROMO-2H-CHROMENE-3-CARBOXYLIC ACID METHYL ESTER
|
177496-79-6
|
C11H9BrO3
|
|
6,8-DIBROMO-2H-CHROMENE-3-CARBOXYLIC ACID METHYL ESTER
|
177496-81-0
|
C11H8Br2O3
|
|
Isooctadecanoic acid, esters with chlorodimethylsilane-2-ethyl-2-(2-propenyloxy)-1,3-propanediol-silicic acid (H4SiO4) tetra-Et ester reaction products
|
177528-07-3
|
|
|
7H-Diimidazo[1,5-a:1,5,4-de]quinoxaline(9CI)
|
177528-39-1
|
C11H8N4
|
|
celosian
|
177529-17-8
|
|
|
GPIb-BP, Jararaca
|
177530-05-1
|
|
|
Rac-Efavirenz
|
177530-93-7
|
C14H9ClF3NO2
|
|
Benzenemethanol, 2-amino-6-methoxy- (9CI)
|
177531-95-2
|
C8H11NO2
|
|
Benzenemethanol, 2-amino-3,6-dimethyl-
|
177531-96-3
|
C9H13NO
|
|
(4-Propylcyclohexyl)Benzene
|
177533-41-4
|
C15H22
|
|
gigantetroneninone
|
177535-01-2
|
C37H66O7
|
|
4-Oxazolidinecarboxylicacid,2,2-dimethyl-,methylester(9CI)
|
177536-17-3
|
C7H13NO3
|
|
2H-1,4-Benzoxazin-5-amine(9CI)
|
177538-70-4
|
C8H8N2O
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(2-phenylethyl)-, (1S-cis)- (9CI)
|
177540-27-1
|
C12H15NO2
|
|
5-(TRIFLUOROMETHYL)-2,3-DIHYDRO-1H-1,4-DIAZEPINE
|
177545-13-0
|
C6H7F3N2
|
|
TRANS-4-(BOC-AMINO)CYCLOHEXYL METHANESULFONATE
|
177545-89-0
|
C12H23NO5S
|
|
1-benzyl-1H-indole-4-carbonitrile(SALTDATA: FREE)
|
177548-00-4
|
C16H12N2
|
|
4-TRIFLUOROMETHYLSULFANYL-BIPHENYL
|
177551-63-2
|
C13H9F3S
|
|
2,2-DIFLUORO-5-PHENYL-BENZO[1,3]DIOXOLE
|
177551-64-3
|
C13H8F2O2
|
|
4-Imidazolidinecarboxylic acid, 1-(chloroacetyl)-2-oxo-, methyl ester, (S)- (9CI)
|
177553-35-4
|
C7H9ClN2O4
|
|
Norfloxacin EP Impurity C
|
177554-64-2
|
C20H27N5O3
|
|
O-n-Butanoyl-2,3,5,6-O-diisopropylidene-α-D-mannofuranoside
|
177562-07-1
|
C16H26O7
|
|
O-n-Butanoyl-2,3-O-diisopropylidene-α-D-mannofuranoside
|
177562-15-1
|
C13H22O7
|
|
Carafiban
|
177563-40-5
|
C24H27N5O5
|
|
Cyclopropanecarboxylic acid, 2-fluoro-, propyl ester, (1S,2S)- (9CI)
|
177564-59-9
|
C7H11FO2
|
|
Cyclopropanecarboxylic acid, 2-fluoro-, propyl ester, (1R-cis)- (9CI)
|
177564-61-3
|
C7H11FO2
|
|
2H-Isoindole-2-carboxylicacid,3a-amino-1,3,3a,7a-tetrahydro-,methylester,
|
177565-40-1
|
C10H14N2O2
|
|
Cyclopentanecarboxaldehyde, 2-methyl-5-(1-methylethenyl)-, (1alpha,2alpha,5alpha)- (9CI)
|
177569-92-5
|
C10H16O
|
|
Cyclohexanecarboxaldehyde, 2-(1-propenyl)-, [1alpha,2beta(Z)]- (9CI)
|
177569-94-7
|
C10H16O
|
|
Bicyclo[3.2.0]heptane-2-carboxylic acid, 7-oxo-, [1S-(1alpha,2alpha,5alpha)]- (9CI)
|
177569-99-2
|
C8H10O3
|
|
Disperse Yellow 235
|
177570-98-8
|
|
|
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)- 4-((4-(4-(4-(1-((1S,2S)-1-etyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4H-1 ,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1H-1,2,4-tr iazol-1-yl)-
|
177571-33-4
|
C37H42F2N8O4
|
|
TETRAISOPROPOXIDE (2,2,6,6-TETRAMETHYL-3,5-HEPTANEDIONATO)TANTALUM)
|
177580-53-9
|
|
|
CYSTEINE(4-METHOXYTRITYL)-OH
|
177582-20-6
|
C23H23NO3S
|
|
FMOC-CYS(MMT)-OH
|
177582-21-7
|
C38H33NO5S
|
|
BENZYL TRANS-4-AMINOMETHYLCYCLOHEXYLCARBAMATE
|
177582-74-0
|
C15H22N2O2
|
|
tert-Butyl (trans-4-aminomethylcyclohexyl)carbamate
|
177583-27-6
|
C12H24N2O2
|
|
ZK164015
|
177583-70-9
|
C30H43NO4S
|
|
2-FLUORODIBENZOTHIOPHENE
|
177586-38-8
|
C12H7FS
|
|
2-Iododibenzothiophene
|
177586-41-3
|
C12H7IS
|
|
Unsatd.(C=18) fatty acids dimers, hydrogenated polymers with adipic acid and 1,6-hexanediol
|
177591-11-6
|
|
|
1,6-Hexanediol, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, .alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl) and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, N-butyl-1-butanamine-blocked
|
177591-52-5
|
|
|
3-Pyridinemethanol,4-hydroxy-(9CI)
|
177592-15-3
|
C6H7NO2
|